Western blot analysis of eight PSP and eight control forebrains demonstrated that DLX1 protein levels do not differ between patients and controls in white matter (Fig. 4c and Supplementary Fig. 5). This evidence concerns the gene DLX1 and supranuclear palsy, progressive, 1.